Improving patient safety through the systematic evaluation of patient outcomes

Canadian Journal of Surgery

Volumn 55, Issue 6, 2012, Pages 418-425

  Forster, Alan J ^a,b   Dervin, Geoff ^a,c   Martin, Claude ^d   Papp, Steven ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d CMAJ   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; HEALTH SURVEY; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT SAFETY; REVIEW; SAFETY; STANDARD; TREATMENT OUTCOME;

CANADA; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT SAFETY; POPULATION SURVEILLANCE; SAFETY MANAGEMENT;

EID: 84872857820     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.007811     Document Type: Review

References (55)

1. The Institute of Medicine. To err is human: building a safer health system. Washington: National Academy Press, 2000.
2. Berwick DM, Calkins DR, McCannon CJ, et al. The 100,000 Lives Campaign: setting a goal and a deadline for improving health care quality. JAMA 2006;295:324-7.
3. de Vries EN, Ramrattan MA, Smorenburg SM, et al. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care 2008;17:216-23.
4. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009;360:491-9.
5. Landrigan CP, Parry GJ, Bones CB, et al. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med 2010;363: 2124-34.
6. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004;170:1678-86.
7. Forster AJ, Asmis TR, Clark HD, et al. Ottawa Hospital Patient Safety Study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital. CMAJ 2004;170:1235-40.
8. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991;324:370-6.
9. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001;322: 517-9.
10. Wilson RM, Runciman WB, Gibberd RW, et al. The Quality in Australian Health Care Study. Med J Aust 1995;163:458-71.
11. Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 2000;38:261-71.
12. Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals I: occurrence and impact. N Z Med J 2002;115:U271.
13. van Walraven C, Austin PC, Jennings A, et al. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009;47:626-33.
14. Runciman WB, Webb RK, Helps SC, et al. A comparison of iatrogenic injury studies in Australia and the USA. II: reviewer behaviour and quality of care. Int J Qual Health Care 2000;12:379-88.
15. Bates DW, Larizgoitia I, Prasopa-Plaizier N, et al.; on behalf of the Research Priority Setting Working Group of the WHO World Alliance for Patient Safety. Global priorities for patient safety research. BMJ 2009; 338:b1775.
16. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003;290:1868-74.
17. Eber MR, Laxminarayan R, Perencevich EN, et al. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med 2010;170:347-53.
18. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-11.
19. Classen DCM, Pestotnik SLM, Evans RSP, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6.
20. Thomas EJ, Petersen LA. Measuring errors and adverse events in health care. J Gen Intern Med 2003;18:61-7.
21. Brennan TA. The Institute of Medicine report on medical errors. Could it do harm? N Engl J Med 2000;342:1123-5.
22. Pronovost PJ, Miller MR, Wachter RM. Tracking progress in patient safety: an elusive target. JAMA 2006;296:696-9.
23. Neumayer L, Mastin M, Vanderhoof L, et al. Using the Veterans Administration National Surgical Quality Improvement Program to improve patient outcomes. J Surg Res 2000;88:58-61.
24. Khuri SF, Daley J, Henderson WG. The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs. Arch Surg 2002;137:20-7.
25. Rowell KS, Turrentine FE, Hutter MM, et al. Use of national surgical quality improvement program data as a catalyst for quality improvement. J Am Coll Surg 2007;204:1293-300.
26. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.
27. Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995;21:541-8.
28. Donchin Y, Gopher D, Olin M, et al. A look into the nature and causes of human errors in the intensive care unit. 1995. Qual Saf Health Care 2003;12:143-7, discussion 147-8.
29. Beckmann U, Bohringer C, Carless R, et al. Evaluation of two methods for quality improvement in intensive care: facilitated incident monitoring and retrospective medical chart review. Crit Care Med 2003;31:1006-11.
30. Chaudhry SI, Olofinboba KA, Krumholz HM. Detection of errors by attending physicians on a general medicine service. J Gen Intern Med 2003;18:595-600.
31. Brennan TA, Localio RJ, Laird NL. Reliability and validity of judgments concerning adverse events suffered by hospitalized patients. Med Care 1989;27:1148-58.
32. Madsen JJ. Comparison of concurrent and retrospective methods of detecting adverse drug reactions. Am J Hosp Pharm 1993;50:2556-7.
33. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003; 290: 1868-74.
34. Bates DW, O'Neil AC, Petersen LA, et al. Evaluation of screening criteria for adverse events in medical patients. Med Care 1995;33: 452-62.
35. Weingart SN, Iezzoni LI, Davis RB, et al. Use of administrative data to find substandard care: validation of the complications screening program. Med Care 2000;38:796-806.
36. McCarthy EP, Iezzoni LI, Davis RB, et al. Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care 2000;38:868-76.
37. Forster AJ, Halil RB, Tierney MG. Pharmacist surveillance of adverse drug events. Am J Health Syst Pharm 2004;61:1466-72.
38. Andrews LB, Stocking C, Krizek T, et al. An alternative strategy for studying adverse events in medical care. Lancet 1997;349:309-13.
39. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
40. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993;8: 289-94.
41. Forster AJ, Fung I, Caughey S, et al. Adverse events detected by clinical surveillance on an obstetric service. Obstet Gynecol 2006;108: 1073-83.
42. Wolff AM, Bourke J, Campbell IA, et al. Detecting and reducing hospital adverse events: outcomes of the Wimmera clinical risk management program. Med J Aust 2001;174:621-5.
43. Wolff AM, Bourke J. Detecting and reducing adverse events in an Australian rural base hospital emergency department using medical record screening and review. Emerg Med J 2002;19:35-40.
44. Murff HJ, Patel VL, Hripcsak G, et al. Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform 2003;36:131-43.
45. Forster AJ, Andrade J, van Walraven C. Validation of a discharge summary term search method to detect adverse events. J Am Med Inform Assoc 2005;12:200-6.
46. Murff HJ, Forster AJ, Peterson JF, et al. Electronically screening discharge summaries for adverse medical events. J Am Med Inform Assoc 2003;10:339-50.
47. Honigman B, Light P, Pulling RM, et al. A computerized method for identifying incidents associated with adverse drug events in outpatients. Int J Med Inform 2001;61:21-32.
48. Hope C, Overhage JM, Seger A, et al. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform 2003;36:92-8.
49. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998;5:305-14.
50. Thomas EJ, Lipsitz SR, Studdert DM, et al. The reliability of medical record review for estimating adverse event rates. Ann Intern Med 2002;136:812-6.
51. Forster AJ, O'Rourke K, Shojania KG, et al. Combining ratings from multiple physician reviewers helped to overcome the uncertainty associated with adverse event classification. J Clin Epidemiol 2007;60: 892-901.
52. Wu AW. Medical error: the second victim. BMJ 2000;320:726-7.
53. Pierluissi E, Fischer MA, Campbell AR, et al. Discussion of medical errors in morbidity and mortality conferences. JAMA 2003;290: 2838-42.
54. McDonnell C, Laxer RM, Roy WL. Redesigning a morbidity and mortality program in a university-affiliated pediatric anesthesia department. Jt Comm J Qual Patient Saf 2010;36:117-25.
55. Lewis S. CMA emerges dazed from cave, writes report. Essays 2010. Available: www.longwoods.com/content/21904 (accessed 2012 Sept. 21).